influenza
type
virus
classifi
antigen
properti
surfac
glycoprotein
hemagglutinin
ha
neuraminidas
na
subtyp
influenza
b
virus
subtyp
histor
three
ha
subtyp
respons
pandem
outbreak
includ
outbreak
caus
novel
influenza
viru
swine
origin
contrast
viru
subtyp
combinatori
possibl
ha
na
detect
wild
bird
poultri
sinc
highli
pathogen
avian
influenza
hpai
virus
particular
subtyp
jump
speci
barrier
caus
ongo
sporad
fatal
outbreak
human
therefor
loom
threat
pandem
influenza
virus
overlook
assay
enabl
rapid
accur
identif
subtyp
influenza
virus
pertin
surveil
outbreak
manag
increas
popular
chipbas
dna
microarray
reflect
tremend
diagnost
potenti
util
rapid
detect
subtyp
influenza
virus
late
hand
respiratori
viru
microarray
produc
commerci
flu
quad
assay
autogenom
inc
carlsbad
ca
fluchip
indevr
boulder
co
fdaclear
vrnat
assay
northbrook
il
last
design
detect
influenza
b
virus
respiratori
syncyti
virus
b
use
glass
slide
array
flu
quad
assay
fluchip
assay
howev
still
research
use
studi
describ
develop
valid
assay
knowledg
first
commerci
avail
integr
labonchip
loc
devic
combin
revers
transcript
rt
pcr
amplif
follow
amplicon
hybrid
dna
microarray
specif
detect
clinic
import
influenza
viru
subtyp
includ
pandem
influenza
virus
hardwar
requir
run
chip
compris
comput
thermal
control
system
tc
enabl
pcr
thermal
cycl
microarray
optic
reader
lean
srl
medolla
itali
accompani
softwar
control
instrument
also
gener
analysi
report
workflow
system
process
time
step
list
belowextract
viral
rna
vrna
sampl
done
either
manual
use
spincolumn
use
autom
extract
system
min
vrna
mix
rtpcr
master
mix
pipet
microfluid
channel
chip
lead
rapid
miniatur
pcr
reactorth
chip
load
onto
thermal
reactor
tc
allow
multiplex
pcr
amplif
perform
onchip
min
hybrid
amplicon
microarray
min
spot
imag
analysi
minchip
total
assay
time
includ
rna
extract
approxim
h
hemagglutinin
ha
neuraminidas
na
gene
use
target
probe
primer
design
gene
sequenc
human
avian
pandem
influenza
influenza
b
virus
download
genbank
influenza
viru
resourc
http
wwwncbinlmnihgovgenomesflufluhtml
well
global
initi
share
influenza
data
gisaid
http
platformgisaidorg
sequenc
align
use
bioedit
sequenc
align
editor
version
highli
conserv
region
result
align
use
probe
primer
design
shown
tabl
haspecif
primer
design
pandem
season
influenza
b
virus
addit
primer
probe
design
na
segment
pandem
facilit
subtyp
revers
primer
synthes
addit
label
sigma
proligo
singapor
captur
probe
design
use
variabl
region
gene
tabl
assay
compris
influenzavirusspecif
pcr
primer
set
forward
revers
psii
primer
amplif
pcrposit
control
plant
origin
tabl
togeth
primer
constitut
primer
mix
influenza
target
captur
probe
rtpcr
control
probe
posit
neg
hybrid
control
probe
tabl
total
respiratori
sampl
throat
nasal
swab
collect
patient
present
influenzalik
ill
fever
cough
sore
throat
headach
muscl
ach
sampl
collect
may
august
sentinel
physician
particip
local
influenza
surveil
programm
specimen
transport
site
collect
nation
public
health
laboratori
nphl
singapor
sampl
process
carri
specimen
subject
influenza
viru
detect
realtim
rtpcr
shellvial
cultur
follow
immunofluoresc
assay
swab
taken
patient
use
flock
swab
copan
diagnost
murrieta
ca
transport
ml
copan
univers
transport
medium
utm
utm
specimen
divid
two
aliquot
one
aliquot
use
viral
cultur
use
standard
shell
vial
techniqu
subject
nucleic
acid
extract
use
biorobot
qiagen
hilden
germani
extract
rna
elut
buffer
nucleic
acid
sampl
store
requir
pcr
analysi
realtim
rtpcr
detect
influenza
viru
describ
spackman
colleagu
sampl
posit
influenza
viru
subtyp
use
protocol
describ
public
health
laboratori
servic
branch
centr
health
protect
chp
depart
health
hong
kong
sar
china
http
wwwchpgovhkfilespdfchpprotocolsforthedetectionofhumanswineinfluenzapdf
detect
pandem
influenza
base
nucleoprotein
np
gene
use
primer
probe
design
nphl
detect
influenza
b
viru
describ
krafft
et
al
rtpcr
reaction
set
use
quantitect
probe
pcr
kit
qiagen
amplif
perform
lightcycl
realtim
pcr
system
roch
mannheim
germani
pcr
protocol
primer
probe
sequenc
avail
upon
request
author
isol
influenza
viru
aliquot
specimen
transport
medium
pass
acrodisc
syring
filter
pall
corp
ann
arbor
mi
inocul
shell
vial
diagnost
hybrid
inc
columbu
oh
contain
monolay
madindarbi
canin
kidney
mdck
cell
two
day
incub
direct
test
use
fluoresceinisothiocyanateconjug
fitc
monoclon
antibodi
light
diagnost
concord
road
billerica
specif
influenza
b
virus
use
detect
differenti
virus
zeiss
invert
fluoresc
microscop
use
examin
sampl
posit
stain
cell
influenzavirusposit
cultur
store
futur
use
viru
isol
mdck
cell
cultur
clinic
specimen
influenza
viru
includ
pandem
influenza
viru
submit
collabor
centr
refer
research
influenza
victorian
infecti
diseas
refer
laboratori
vidrl
nation
influenza
centr
region
laboratori
hospit
australia
new
zealand
asiapacif
region
virus
grown
mdck
cell
andor
embryon
chicken
egg
viru
growth
monitor
observ
cytopath
effect
presenc
haemagglutin
activ
observ
use
turkey
red
blood
cell
describ
previous
isol
test
use
standard
haemagglutin
inhibit
assay
hai
panel
refer
virus
homolog
ferret
antisera
vrna
extract
either
clinic
specimen
virus
grown
mdck
cell
cultur
describ
previous
realtim
rtpcr
also
perform
determin
type
subtyp
virus
clinic
specimen
describ
previous
multiplex
rtpcr
reaction
perform
use
quantitect
virusrox
vial
kit
qiagen
ontario
canada
total
volum
rtpcr
master
mix
prepar
ad
follow
compon
qt
viru
nr
master
mix
primer
mix
rnasefre
water
rnase
inhibitor
qt
viru
rt
mix
rna
templat
psii
amplif
control
psii
vitrotranscrib
rna
deriv
chloroplastencod
gene
psba
mungbean
plant
genbank
rtpcr
mix
pipet
chip
inlet
lead
pcr
microreactor
amplif
take
place
chip
seal
place
tc
cycl
paramet
use
follow
min
min
cycl
sec
sec
sec
upon
complet
rtpcr
chip
extract
tc
unseal
hybrid
amplicon
microarray
hybrid
mix
pipet
chip
inlet
final
buffer
composit
mm
phosphat
buffer
mm
kcl
mm
nacl
denhardt
solut
tween
nm
posit
hybrid
control
tabl
chip
reseal
place
tc
heat
denatur
amplicon
perform
min
follow
hybrid
hybrid
chip
unseal
wash
min
room
temperatur
falcon
tube
fill
ml
sodium
dodecyl
sulfat
dri
centrifug
rpm
min
falcon
tube
dri
chip
scan
optic
reader
lean
srl
spot
segment
intens
calcul
microarray
imag
perform
overlay
virtual
grid
microarray
imag
use
corner
featur
refer
point
spot
imag
detect
within
grid
comput
background
signal
valu
signaltonois
ratio
defin
posit
result
recombin
plasmid
bear
synthet
pandem
influenza
ha
na
gene
promot
sequenc
end
obtain
integr
dna
technolog
inc
idt
inc
coralvil
ia
recombin
plasmid
bear
ha
na
gene
clinic
isol
influenza
influenza
b
atcc
virus
gener
inhous
plasmid
linear
restrict
digest
use
sali
new
england
biolab
inc
ipswich
na
gene
sacii
promega
madison
wi
ha
gene
vitro
transcript
ivt
gener
use
vitro
transcript
system
promega
quantifi
use
agil
bioanalyz
rna
nano
kit
agil
technolog
santa
clara
ca
ivt
ha
na
gene
segment
clinic
isol
influenza
virus
atcc
isol
influenza
b
viru
use
determin
analyt
sensit
rna
concentr
measur
use
nanodrop
spectrophotomet
nanodrop
technolog
wilmington
de
rna
copi
number
calcul
use
follow
formula
rna
concentr
x
rna
transcript
length
bp
x
x
x
tenfold
serial
dilut
ha
na
rna
transcript
made
lod
cutoff
valu
determin
triplic
rna
transcript
lod
lowest
concentr
rna
could
give
detect
rate
viru
type
triplic
cutoff
valu
detect
defin
lowest
rna
concentr
would
yield
posit
assay
result
time
analyt
specif
assay
evalu
use
panel
nine
commonli
found
noninfluenza
respiratori
virus
purchas
american
type
cultur
collect
atcc
manassa
va
strain
includ
respiratori
syncyti
viru
atcc
respiratori
syncyti
viru
atcc
human
coronaviru
atcc
human
parainfluenza
viru
atcc
human
parainfluenza
viru
atcc
human
parainfluenza
viru
atcc
human
rhinoviru
atcc
human
adenoviru
type
atcc
human
adenoviru
type
atcc
product
viral
stock
perform
propag
viru
appropri
cell
line
tissu
cultur
infecti
dose
viru
determin
rna
extract
viru
sampl
use
qiaamp
viral
mini
kit
qiagen
test
triplic
high
rna
concentr
intraassay
specif
evalu
test
three
influenza
virus
season
influenza
influenza
influenza
b
ivt
na
ha
pandem
influenza
viru
primer
captur
probe
assay
clinic
sampl
subject
nucleic
acid
extract
use
biorobot
qiagen
extract
nucleic
acid
use
assay
reaction
evalu
carri
three
local
hospit
result
collat
present
singl
tabl
tabl
quantifi
viral
stock
influenza
viru
influenza
b
viru
neg
sampl
use
assess
intraassay
interassay
reproduc
low
moder
strong
posit
prepar
influenza
influenza
b
viru
rna
ct
valu
low
moder
strong
posit
sampl
respect
whilst
ct
valu
influenza
b
low
moder
strong
posit
sampl
respect
lod
cutoff
rna
copi
number
concentr
provid
basi
low
medium
posit
test
carri
concentr
use
influenza
viru
sampl
triplic
neg
sampl
also
triplic
studi
conduct
two
run
per
day
two
local
test
site
two
oper
test
period
day
percentag
agreement
expect
result
calcul
sensit
specif
assay
calcul
comparison
combin
refer
method
includ
rtpcr
sequenc
ha
segment
viru
cultur
immunoassay
sensit
specif
result
confid
interv
ci
proport
calcul
use
wilson
score
method
without
continu
correct
lod
defin
rna
concentr
would
yield
posit
assay
result
time
viru
type
test
lod
determin
copiesreact
tabl
cutoff
detect
defin
rna
copi
number
could
detect
time
determin
copi
influenza
viru
influenza
b
viru
pandem
season
cutoff
determin
higher
copiesreact
assay
test
panel
noninfluenza
virus
differ
influenza
viru
subtyp
influenza
b
viru
crossreact
observ
influenza
virus
test
noninfluenza
respiratori
virus
crossreact
note
pandem
influenza
captur
probe
human
coronaviru
influenza
b
captur
probe
human
adenoviru
type
consid
minor
crossreact
probe
signaltonois
ratio
weakli
posit
also
case
one
triplic
sampl
posit
henc
overal
analyt
specif
assay
calcul
assay
valid
three
site
singapor
use
total
respiratori
sampl
tabl
assay
show
good
sensit
excel
specif
influenza
virus
test
system
evalu
use
clinic
cellcultur
viru
sampl
addit
avian
influenza
viru
test
also
perform
overal
sampl
test
assay
result
specimen
concord
refer
method
n
influenzaneg
sampl
test
neg
specif
assay
detect
influenza
virus
posit
sampl
follow
pandem
season
influenza
b
observ
research
investig
indic
assay
abl
detect
lineag
influenza
b
virus
yamagata
victoria
lineag
influenza
virus
differ
clade
includ
reproduc
assay
present
tabl
test
rna
copi
number
would
give
moder
strong
posit
influenza
b
assay
highli
reproduc
expect
low
rna
copi
number
test
reproduc
drop
almost
influenza
b
report
develop
evalu
portabl
easytous
diagnost
platform
assay
type
subtyp
human
influenza
viru
test
base
onchip
multiplex
rtpcr
amplif
follow
detect
use
microarray
perform
fairli
rapidli
take
h
complet
tc
thermal
reactor
accommod
maximum
five
chip
run
either
simultan
independ
use
differ
protocol
modular
natur
system
allow
linkup
one
tc
unit
comput
henc
enabl
system
adapt
throughput
need
either
larg
smallscal
diagnost
set
laboratori
reproduc
data
studi
suggest
assay
easi
handl
import
consider
outbreak
situat
overal
clinic
sensit
influenza
virus
test
specif
valu
compar
obtain
similar
microarray
base
influenza
viru
type
assay
known
microarraybas
detect
type
influenza
virus
gener
less
sensit
perform
realtim
pcr
analyt
sensit
determin
copiesreact
influenza
type
figur
similar
report
huang
et
al
rna
copiesreact
season
influenza
b
viru
detect
limit
multiplex
pcr
assay
report
copi
influenza
influenza
b
virus
explain
sampl
type
confirm
refer
method
cell
cultur
realtim
rt
pcr
miss
assay
laboratori
use
realtim
pcr
detect
influenza
viru
follow
second
subtyp
pcr
influenza
posit
detect
anticip
assay
eas
process
sinc
detect
subtyp
done
simultan
onchip
multiplex
capabl
realtim
pcr
reaction
typic
limit
fourplex
restrict
number
fluoresc
acquisit
channel
present
pcr
instrument
contrast
detect
format
assay
lowdensityarraybas
allow
ten
hundr
captur
probe
spot
correspondingli
allow
similar
number
amplicon
detect
henc
array
much
greater
detect
capabl
robust
parallel
test
realtim
pcr
given
high
mutat
frequenc
influenza
viru
genom
effort
taken
increas
specif
assay
includ
use
short
captur
probe
nucleotid
well
incorpor
probe
redund
captur
probe
design
detect
section
target
gene
may
use
overcom
problem
misdiagnosi
due
captur
probe
fail
hybrid
amplicon
result
gene
polymorph
assay
captur
probe
crossreact
observ
pandem
influenza
probe
human
coronaviru
influenza
b
captur
probe
human
adenoviru
type
test
clinic
sampl
fals
posit
natur
unlik
hybrid
one
captur
probe
instead
probe
influenza
b
viru
three
probe
pandem
insuffici
permit
softwar
call
posit
result
instead
oper
alert
particular
influenza
gene
segment
detect
retest
advis
work
appli
stringent
hybrid
wash
may
solv
problem
crossreact
summari
develop
labonchip
devic
clinic
evalu
local
melbourn
system
found
reliabl
accur
identif
clinic
signific
influenza
virus
could
potenti
prove
valuabl
method
routin
influenza
surveil
well
outbreak
event
